| Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages S Wang, J Tang, T Sun, X Zheng, J Li, H Sun, X Zhou, C Zhou, H Zhang, ... Scientific reports 7 (1), 1339, 2017 | 200 | 2017 |
| A review on curability of cancers: more efforts for novel therapeutic options are needed S Wang, Y Liu, Y Feng, J Zhang, J Swinnen, Y Li, Y Ni Cancers 11 (11), 1782, 2019 | 81 | 2019 |
| PD-L1 expression as poor prognostic factor in patients with non-squamous non-small cell lung cancer C Zhou, J Tang, H Sun, X Zheng, Z Li, T Sun, J Li, S Wang, X Zhou, H Sun, ... Oncotarget 8 (35), 58457, 2017 | 63 | 2017 |
| Survival changes in patients with synovial sarcoma, 1983-2012 S Wang, R Song, T Sun, B Hou, G Hong, S Mallampati, H Sun, X Zhou, ... Journal of Cancer 8 (10), 1759, 2017 | 57 | 2017 |
| Utilisation of chick embryo chorioallantoic membrane as a model platform for imaging-navigated biomedical research L Chen, S Wang, Y Feng, J Zhang, Y Du, J Zhang, C Van Ongeval, Y Ni, ... Cells 10 (2), 463, 2021 | 54 | 2021 |
| Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983–2012 S Wang, H Sun, Z Xie, J Li, G Hong, D Li, S Mallampati, X Zhou, C Zhou, ... Oncotarget 7 (37), 59820, 2016 | 54 | 2016 |
| Improved survival in ovarian cancer, with widening survival gaps of races and socioeconomic status: a period analysis, 1983-2012 J Wu, H Sun, L Yang, Y Deng, Y Yan, S Wang, G Yang, H Ma Journal of Cancer 9 (19), 3548, 2018 | 48 | 2018 |
| Incidence and prognosis of liver metastasis at diagnosis: a pan-cancer population-based study S Wang, Y Feng, J Swinnen, R Oyen, Y Li, Y Ni American Journal of Cancer Research 10 (5), 1477, 2020 | 39 | 2020 |
| Increased survival rates in gastric cancer, with a narrowing gender gap and widening socioeconomic status gap: a period analysis from 1984 to 2013 F Sun, H Sun, X Mo, J Tang, Y Liao, S Wang, Y Su, H Ma Journal of Gastroenterology and Hepatology 33 (4), 837-846, 2018 | 35 | 2018 |
| Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades T Sun, S Wang, H Sun, J Wen, G An, J Li Leukemia & lymphoma 59 (1), 49-58, 2018 | 34 | 2018 |
| Survival improvement in patients with non–small cell lung cancer between 1983 and 2012: Analysis of the Surveillance, Epidemiology, and End Results database S Wang, T Sun, H Sun, X Li, J Li, X Zheng, S Mallampati, H Sun, X Zhou, ... Tumor Biology 39 (5), 1010428317691677, 2017 | 32 | 2017 |
| The epidemiological trend of acute myeloid leukemia in childhood: a population-based analysis X Chen, J Pan, S Wang, S Hong, S Hong, S He Journal of Cancer 10 (20), 4824, 2019 | 28 | 2019 |
| DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection S Wang, H Ma, X Li, X Mo, H Zhang, L Yang, Y Deng, Y Yan, G Yang, ... Aging (Albany NY) 12 (2), 1171, 2020 | 27 | 2020 |
| Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis R Cai, R Song, P Pang, Y Yan, Y Liao, C Zhou, S Wang, X Zhou, H Wang, ... BMC cancer 17, 1-9, 2017 | 27 | 2017 |
| The fluctuating incidence, improved survival of patients with breast cancer, and disparities by age, race, and socioeconomic status by decade, 1981–2010 G Lu, J Li, S Wang, J Pu, H Sun, Z Wei, Y Ma, J Wang, H Ma Cancer Management and Research, 4899-4914, 2018 | 26 | 2018 |
| Incidence and survival changes in patients with esophageal adenocarcinoma during 1984–2013 Z Haiyu, P Xiaofeng, M Xiangqiong, Q Junlan, Z Xiaobin, W Shuncong, ... BioMed research international 2019 (1), 7431850, 2019 | 23 | 2019 |
| Chemotherapy plus dendritic cells co-cultured with cytokine-induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: A meta-analysis C Zhou, D Liu, J Li, H Sun, X Zheng, S Wang, G Hong, S Mallampati, ... Oncotarget 7 (52), 86500, 2016 | 19 | 2016 |
| Chemotherapy combined with dendritic cell vaccine and cytokine-induced killer cells in the treatment of colorectal carcinoma: a meta-analysis X Zhou, X Mo, J Qiu, J Zhao, S Wang, C Zhou, Y Su, Z Lin, H Ma Cancer management and research, 5363-5372, 2018 | 17 | 2018 |
| Long‐term survival rates of patients with stage III–IV Hodgkin lymphoma according to age, sex, race, and socioeconomic status, 1984–2013 Y Li, H Sun, Y Yan, T Sun, S Wang, H Ma The Oncologist 23 (11), 1328-1336, 2018 | 14 | 2018 |
| Predicting therapeutic efficacy of vascular disrupting agent CA4P in rats with liver tumors by hepatobiliary contrast agent Mn-DPDP-Enhanced MRI Y Liu, Q Guan, X Kong, F De Keyzer, Y Feng, F Chen, J Yu, J Liu, S Song, ... Translational oncology 13 (1), 92-101, 2020 | 11 | 2020 |
